Management of Long QT Syndrome

Initial Assessment and Monitoring

The American College of Cardiology recommends obtaining a baseline ECG and measuring QTc interval using appropriate correction formulas, with normal values being <430 ms for males and <450 ms for females 2
A QTc >500 ms or an increase of >60 ms from baseline significantly increases the risk of torsades de pointes 2
The American College of Cardiology suggests checking serum electrolytes, particularly potassium and magnesium levels, and correcting any abnormalities immediately 2, 3
Identifying and discontinuing any QT-prolonging medications is crucial, as these are potentially harmful in patients with Long QT syndrome 3

The American College of Cardiology recommends administering beta-blocker therapy immediately for patients with Long QT syndrome with a resting QTc greater than 470 ms 3, 4
Correcting electrolyte abnormalities, particularly maintaining serum potassium between 4.5-5 mEq/L, can shorten the QT interval and reduce the risk of torsades de pointes 5, 2
Discontinuing all QT-prolonging medications and avoiding concomitant use of multiple QT-prolonging drugs is essential 1, 2
Administering 2g IV magnesium sulfate immediately, regardless of serum magnesium level, is recommended for patients with torsades de pointes 5, 2

The American College of Cardiology suggests assessing for high-risk features, including QTc >500 ms, genotypes LQT2 and LQT3, females with genotype LQT2, age <40 years, and history of syncope 3, 4
For high-risk patients with symptomatic Long QT syndrome in whom a beta blocker is ineffective or not tolerated, intensifying therapy with additional medications, left cardiac sympathetic denervation, and/or an ICD may be necessary 3, 4

Recognizing that fever can prolong the QT interval in patients with Long QT syndrome type 2, and reducing fever with antipyretics is important 1, 6
Being aware that approximately 10-36% of genotype-positive patients with Long QT syndrome have QTc intervals ≤440 ms, most commonly patients with Long QT syndrome type 1, is crucial 1, 6
Avoiding the use of other antiarrhythmic drugs, as they may further prolong the QT interval, is recommended 5